UNSPSC 85552529: Replacement of left upper eyelid with autologous tissue substitute, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left upper eyelid with autologous tissue substitute, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08RPX7Z

UNSPSC 85552529 Replacement of left upper eyelid with autologous tissue substitute, external approach is a Commodity code that shows little relevant recent activity under state and local procurement. The recent opportunities tagged to this code reflect medical evaluation and health professional staffing services—occupational medical surveillance, disability evaluation coordination, surgical benefit management, pharmacy benefit administration, and temporary clinical staffing—none of which align with reconstructive eyelid surgery or tissue-substitute procedures. The mismatch suggests either a data-coding error in the originating procurement systems or a fundamental misalignment between the UNSPSC taxonomy and how state and local agencies classify health services contracts.

State and local buyers posting under this code include county health systems (Santa Clara), county departments (Collier County, Harris County), municipal retirement offices (Phoenix), transit authorities (Washington State Ferries), and cities (Long Beach). No issuing body appears more than once in the recent block. Geographically, recent activity spans Arizona, California, Florida, Texas, and Washington. The most concrete opportunities are the Phoenix Retirement Office's independent medical evaluation services RFP (due October 16, 2026; $750,000 maximum over five years), the City of Long Beach's surgical benefit carve-out program RFP (due October 7, 2026), and the Washington State Department of Transportation occupational medical surveillance services RFP for the State Ferries (due October 9, 2026). If your firm pursues reconstructive surgery or tissue-substitute procurement, this code does not surface relevant state and local demand.